Literature DB >> 20689537

Big pharma moves from 'blockbusters' to 'niche busters'.

Elie Dolgin.   

Abstract

Mesh:

Year:  2010        PMID: 20689537     DOI: 10.1038/nm0810-837a

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  15 in total

1.  Orphan diseases: state of the drug discovery art.

Authors:  Claude-Henry Volmar; Claes Wahlestedt; Shaun P Brothers
Journal:  Wien Med Wochenschr       Date:  2016-01-27

2.  Alkaptonuria: leading to the treasure in exceptions.

Authors:  Timothy M Cox
Journal:  JIMD Rep       Date:  2011-12-06

3.  Orphan drug development in China - Turning challenges into opportunities.

Authors:  Xiaowei Jin; Li Chen
Journal:  Intractable Rare Dis Res       Date:  2016-11

4.  Access to High Cost Cancer Medicines Through the Lens of an Australian Senate Inquiry-Defining the "Goods" at Stake.

Authors:  Narcyz Ghinea; Miles Little; Wendy Lipworth
Journal:  J Bioeth Inq       Date:  2017-07-18       Impact factor: 1.352

5.  Animal models and conserved processes.

Authors:  Ray Greek; Mark J Rice
Journal:  Theor Biol Med Model       Date:  2012-09-10       Impact factor: 2.432

Review 6.  The Nuremberg Code subverts human health and safety by requiring animal modeling.

Authors:  Ray Greek; Annalea Pippus; Lawrence A Hansen
Journal:  BMC Med Ethics       Date:  2012-07-08       Impact factor: 2.652

Review 7.  Systematic reviews of animal models: methodology versus epistemology.

Authors:  Ray Greek; Andre Menache
Journal:  Int J Med Sci       Date:  2013-01-11       Impact factor: 3.738

8.  Why the Shift? Taking a Closer Look at the Growing Interest in Niche Markets and Personalized Medicine.

Authors:  Shannon Gibson; Hamid R Raziee; Trudo Lemmens
Journal:  World Med Health Policy       Date:  2015-03

9.  Paying for On-Patent Pharmaceuticals: Limit Prices and the Emerging Role of a Pay for Outcomes Approach.

Authors:  Richard L Fuller; Norbert Goldfield
Journal:  J Ambul Care Manage       Date:  2016 Apr-Jun

Review 10.  Patent cliff and strategic switch: exploring strategic design possibilities in the pharmaceutical industry.

Authors:  Chie Hoon Song; Jeung-Whan Han
Journal:  Springerplus       Date:  2016-05-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.